|07:34 EDT||SGNT||Sagent Pharmaceuticals CEO Jeffrey Yordon retires|
The board of Sagent Pharmaceuticals announced that Jeffrey Yordon, chairman and CEO, has informed the board of his decision to retire from the company. He will remain a member of the board. Frank Kung, Ph.D., a member of Sagent's board since 2006, has been named chairman. The board will immediately begin the search for a new CEO. In the interim, the board has formed an Executive Management Committee to lead the company.